A World of Knowledge
    Technology

    Better biosensor technology created for stem cells

    Researchers have created better biosensor technology using a newly developed instrument that may lead to safe stem cell therapies for treating Alzheimer's and Parkinson's diseases and other neurological disorders.



    This unique biosensing platform consists of ultrathin graphene layers and gold nanostructures. Photo: Letao Yang, KiBum Lee, Jin-Ho Lee and Sy-Tsong (Dean) Chueng


    The technology, which features a unique graphene and gold-based platform and high-tech imaging, monitors the fate of stem cells by detecting genetic material (RNA) involved in turning such cells into brain cells (neurons).

    Because stem cells can become many different types of cells, stem cell therapy shows promise for the regenerative treatment of neurological disorders such as Alzheimer's, Parkinson's, stroke and spinal cord injury, with diseased cells needing replacement or repair.

    But characterizing stem cells and controlling their fate must be resolved before using them in treatments. The formation of tumors and uncontrolled transformation of stem cells remain key barriers.

    "A critical challenge is ensuring high sensitivity and accuracy in detecting biomarkers -- indicators such as modified genes or proteins -- within the complex stem cell microenvironment," said senior author KiBum Lee of Rutgers University. "The technology, which took four years to develop, has demonstrated great potential for analyzing a variety of interactions in stem cells."

    The scientists' unique biosensing platform consists of an array of ultrathin graphene layers and gold nanostructures. The platform, combined with high-tech imaging, detects genes and characterizes different kinds of stem cells with greater reliability, selectivity and sensitivity than today's biosensors.

    The team believes the technology can benefit a range of applications. By developing simple, rapid and accurate sensing platforms, the researchers aim to facilitate treatment of neurological disorders through stem cell therapy. (National Science Foundation)

    NOVEMBER 15, 2019



    YOU MAY ALSO LIKE

    With a brief glance, facial recognition software can categorize gender with remarkable accuracy. But if that face belongs to a transgender person, such systems get it wrong more than one third of the time, according to new CU Boulder research.
    A strip of chromatography paper similar to that used in rapid pregnancy tests is the basis of a bio-sensor for detecting malaria that has been developed by Brazilian researchers.
    U.S. electric car manufacturer Tesla is close to testing a long-haul self-driving electric truck that could drive in convoys following a lead vehicle.
    Researchers at Carnegie Mellon University's Robotics Institute have enabled a computer to understand the body poses and movements of multiple people from video in real time -- including, for the first time, the pose of each individual's fingers.
    Heat is commonly regarded as computing's mortal enemy. Two researchers, however, developed a method to use heat as an alternative energy source.
    South Korean electronics giant Samsung says it will no longer manufacture its troubled Galaxy Note 7 smartphone after numerous reports around the globe of overheating.

    © 1991-2024 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact